Sort   by:  
 Page size 
UnknownReducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
Not available
S-EPMC3427022 | biostudies-literature
UnknownNatural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
Not available
S-EPMC9395853 | biostudies-literature
UnknownFactors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London.
Not available
S-EPMC7396540 | biostudies-literature
UnknownMetabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma.
Not available
S-EPMC10121512 | biostudies-literature
UnknownSpecialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.
Not available
S-EPMC8419540 | biostudies-literature
UnknownTime-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
Not available
S-EPMC8777559 | biostudies-literature
UnknownDeterminants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Not available
S-EPMC8023206 | biostudies-literature
UnknownImpact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
Not available
S-EPMC10798088 | biostudies-literature
UnknownRisk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Not available
S-EPMC8366163 | biostudies-literature
UnknownCOVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
Not available
S-EPMC9047221 | biostudies-literature
Sort   by:  
 Page size